Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Neoplasm”

1,059 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,059 results

Testing effectiveness (Phase 2)Study completedNCT03520231
What this trial is testing

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

Who this might be right for
Urothelial CarcinomaKidney CancerUreter Cancer+1 more
University Health Network, Toronto 6
Testing effectiveness (Phase 2)Study completedNCT01529411
What this trial is testing

Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer

Who this might be right for
Carcinoma, Transitional Cell
Spanish Oncology Genito-Urinary Group 86
Early research (Phase 1)Not Yet RecruitingNCT07053735
What this trial is testing

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Peking University First Hospital 30
Early research (Phase 1)Active Not RecruitingNCT04794699
What this trial is testing

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Who this might be right for
Solid Tumor
IDEAYA Biosciences 169
Not applicableLooking for participantsNCT06863844
What this trial is testing

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Who this might be right for
Urothelial Neoplasm
IRCCS Azienda Ospedaliero-Universitaria di Bologna 210
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableLooking for participantsNCT05321316
What this trial is testing

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)UnknownNCT03209206
What this trial is testing

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 84
Testing effectiveness (Phase 2)Looking for participantsNCT07043972
What this trial is testing

Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Fox Chase Cancer Center 55
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Testing effectiveness (Phase 2)Looking for participantsNCT07193511
What this trial is testing

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+1 more
Avenzo Therapeutics, Inc. 355
Testing effectiveness (Phase 2)Looking for participantsNCT07421700
What this trial is testing

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Who this might be right for
Urothelial CancerAdvanced/Metastatic Urothelial CancerUrothelial Carcinoma
Pfizer 132
Testing effectiveness (Phase 2)UnknownNCT04565275
What this trial is testing

ICP-192 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsUrothelial CarcinomaCholangiocarcinoma
Beijing InnoCare Pharma Tech Co., Ltd. 45
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643
What this trial is testing

Avelumab Program Rollover Study

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 205
Early research (Phase 1)Ended earlyNCT02298153
What this trial is testing

Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110)

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)UC (Urothelial Cancer)
Incyte Corporation 29
Not applicableUnknownNCT05893316
What this trial is testing

UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

Who this might be right for
HematuriaUrothelial Carcinoma
Changhai Hospital 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03029832
What this trial is testing

MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy

Who this might be right for
Urothelial Carcinoma
Genentech, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00066352
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University Health Network, Toronto
Load More Results